Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zivana Tezak

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Proteomics|August 23, 2011
Regulatory perspective on translating proteomic biomarkers to clinical diagnosticsJinong Li, Kellie B Kelm, Zivana Tezak
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Human Genomics|February 8, 2006
FDA perspectives on potential microarray-based clinical diagnosticsZivana Tezak, Daya Ranamukhaarachchi, Estelle Russek-Cohen, et al.
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Therapeutic Delivery|July 27, 2012
Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicineKim E Sapsford, Zivana Tezak, Marina Kondratovich, et al.
Clinical Chemistry|September 3, 2011
Direct-to-consumer genetic testing: reliable or risky?David H Spencer, Christina Lockwood, Eric Topol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesisZivana Tezak, Eric P Hoffman, Jennica L Lutz, et al.
Human Mutation|January 29, 2003
Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiencyZivana Tezak, Paola Prandini, Marco Boscaro, et al.
Journal of the National Cancer Institute|June 13, 2024
Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and reviewLyndsay Harris, Lalitha K Shankar, Claire Hildebrandt, et al.
Clinical Chemistry|December 17, 2009
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnosticsHenry Rodriguez, Zivana Tezak, Mehdi Mesri, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Proteomics|August 23, 2011
Regulatory perspective on translating proteomic biomarkers to clinical diagnosticsJinong Li, Kellie B Kelm, Zivana Tezak
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Human Genomics|February 8, 2006
FDA perspectives on potential microarray-based clinical diagnosticsZivana Tezak, Daya Ranamukhaarachchi, Estelle Russek-Cohen, et al.
Drug Discovery Today. Technologies|July 2, 2014
Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performanceElizabeth Mansfield, Zivana Tezak, Sousan Altaie, et al.
Therapeutic Delivery|July 27, 2012
Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicineKim E Sapsford, Zivana Tezak, Marina Kondratovich, et al.
Clinical Chemistry|September 3, 2011
Direct-to-consumer genetic testing: reliable or risky?David H Spencer, Christina Lockwood, Eric Topol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesisZivana Tezak, Eric P Hoffman, Jennica L Lutz, et al.
Human Mutation|January 29, 2003
Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiencyZivana Tezak, Paola Prandini, Marco Boscaro, et al.
Journal of the National Cancer Institute|June 13, 2024
Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and reviewLyndsay Harris, Lalitha K Shankar, Claire Hildebrandt, et al.
Clinical Chemistry|December 17, 2009
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnosticsHenry Rodriguez, Zivana Tezak, Mehdi Mesri, et al.
Pageof 3